Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxins deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxins deleterious effects. Raxibacumab can be used for anti-anthrax research[1][2].
Molecular Weight:
(142.96 kDa)
Purity:
98.88
CAS Number:
[565451-13-0]
Target:
Bacterial
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted